Letters to the Editor

dc.contributor.authorSahin, S.
dc.contributor.authorKarsidag, S.
dc.date.accessioned2024-07-12T21:40:51Z
dc.date.available2024-07-12T21:40:51Z
dc.date.issued2009en_US
dc.department[Belirlenecek]en_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1097/NRL.0b013e3181883de7
dc.identifier.issn1074-7931
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-78650759195en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage51en_US
dc.identifier.urihttps://doi.org/10.1097/NRL.0b013e3181883de7
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7523
dc.identifier.volume15en_US
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherLippincott Williams and Wilkinsen_US
dc.relation.ispartofNeurologisten_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY08981
dc.subjectAnticoagulant Agenten_US
dc.subjectHumanen_US
dc.subjectLetteren_US
dc.subjectMedical Literatureen_US
dc.subjectPriority Journalen_US
dc.subjectProphylaxisen_US
dc.subjectRisk Factoren_US
dc.subjectStrokeen_US
dc.subjectThromboembolismen_US
dc.titleLetters to the Editoren_US
dc.typeLetter
dspace.entity.typePublication

Dosyalar